Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 2366 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 2812 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 3227 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 3707 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4413 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4640 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4738 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4800 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4862 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4885 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 4963 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5067 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5098 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5227 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5569 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5592 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 5703 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 6025 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 6379 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 6592 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 6638 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 6713 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7010 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7467 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7469 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7478 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7518 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7588 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7762 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 7939 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8070 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8081 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8086 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8153 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8278 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8374 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8417 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8518 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 8800 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 9006 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 9219 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 9270 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 9731 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 9785 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10289 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10386 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10449 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10454 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10658 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10661 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10767 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 10770 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 11577 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 11604 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 11986 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 12002 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 12690 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 13203 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 13318 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 13768 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 14119 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 14647 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 14766 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 15999 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 16100 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 16237 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 16388 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 16577 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 17071 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 17979 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 18564 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 19136 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 19856 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 19878 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 19929 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 21163 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 21874 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 21959 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 22010 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 24337 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 24787 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 25054 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 26580 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 26723 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 28677 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 32311 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 33509 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 36011 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 37780 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 52518 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 55011 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 60374 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 63725 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 68551 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 75087 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 87560 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 102351 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 135064 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 138773 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+H)+ | 1254532 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 1771 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 2907 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 3261 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 3519 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 3578 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 3895 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 4185 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 4609 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 4739 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 5042 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 5127 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 6081 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 6106 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 6157 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 6214 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 6611 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 6829 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 6924 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 7355 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 7356 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 8927 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 10101 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 10959 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 12078 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 12139 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 12436 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 12716 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 12956 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 13363 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 14085 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 14628 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 14659 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 14862 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 15095 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 15921 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 16014 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 16609 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 16656 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 16850 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 17475 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 17583 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 18342 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 19151 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 19209 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 19233 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 19467 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 20331 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 21481 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 22505 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 23097 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 23711 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 25131 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 25567 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 26075 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 27054 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 27690 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 29663 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 30196 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 30656 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 31320 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 31936 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 34005 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 34006 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 36229 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 36258 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 37612 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 38225 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 39633 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 41818 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 43318 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 45847 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 50354 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 52559 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | 262878 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (CAS# 25518-54-1); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |